Abstract
This chapter describes the case of a girl with a history of localized scleroderma (LS) who developed chronic and progressive seizures which were associated with focal brain lesions and chronic progression of the brain lesions. Localized scleroderma (LS) is an uncommon autoimmune condition of the skin that may be associated with head and facial lesions in one-fourth and neurological complications in one-fifth of those with head/facial lesions. Brain MRI may show atrophy or focal T2 hyperintensities on the side ipsilateral to the skin changes. Progression of brain lesions may occur insidiously. While no randomized control trials have been performed on immunotherapy for this condition, methotrexate, steroids, cyclophosphamide, mycophenolate mofetil, and azathioprine have been tried and may be effective.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Torok KS. Pediatric scleroderma: systemic or localized forms. Pediatr Clin North Am. 2012;59:381–405.
Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, Cuttica R, Higgins GC, Van Suijlekom-Smit LW, Moore TL, Lindsley C, Garcia-Consuegra J, Esteves Hilario MO, Lepore L, Silva CA, Machado C, Garay SM, Uziel Y, Martini G, Foeldvari I, Peserico A, Woo P, Harper J. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford). 2006;45:614–20.
Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, Espada G, Corona F, Mukamel M, Vesely R, Musiej-Nowakowska E, Chaitow J, Ros J, Apaz MT, Gerloni V, Mazur-Zielinska H, Nielsen S, Ullman S, Horneff G, Wouters C, Martini G, Cimaz R, Laxer R, Athreya BH. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52:2873–81.
Appenzeller S, Montenegro MA, Dertkigil SS, Sampaio-Barros PD, Marques-Neto JF, Samara AM, Andermann F, Cendes F. Neuroimaging findings in scleroderma en coup de sabre. Neurology. 2004;62:1585–9.
Grosso S, Fioravanti A, Biasi G, Conversano E, Marcolongo R, Morgese G, Balestri P. Linear scleroderma associated with progressive brain atrophy. Brain Dev. 2003;25:57–61.
Amaral TN, Peres FA, Lapa AT, Marques-Neto JF, Appenzeller S. Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum. 2013;43:335–47.
Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S, Cartwright V, Cidon M, Inman CJ, Jerath R, O’Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res. 2012;64:1175–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Yeh, E.A., Weinstock-Guttman, B. (2017). Neuroinflammatory Disease in Association with Morphea (Localized Scleroderma). In: Waubant, E., Lotze, T. (eds) Pediatric Demyelinating Diseases of the Central Nervous System and Their Mimics. Springer, Cham. https://doi.org/10.1007/978-3-319-61407-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-61407-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61405-2
Online ISBN: 978-3-319-61407-6
eBook Packages: MedicineMedicine (R0)